Font size
WorksheetsNOBELIS SMART Therapy Manager
Total questions: 20
Worksheet time: 19mins
Please Enter your Full Name
Please enter your HQ name
Please Enter your Employee Code
Please enter your Designation (ABM/RBM/ZBM)
TRIUMVIRATE : THE TARGET OF OADs (Select right 3)
Impaired β-cell
function
increase Glucose reabsorption
Insulin resistance
Increased Hepatic glucose
30 seconds
Q.
Conversion of glucose to Glycogen
answer choices
Glycogenesis
Glycolysis
Glucogenesis
Gluconeogene
Justoza-M offers benefits across the Cardio-Renal-Metabolic Continuum and shows reduction in CV mortality and HHF by ___ according to DECLARE TIMI 58?
29%
17%
39%
25%
___ proportion of patients on Justoza-M achieved weight ;loss reduction >=5% compared to 2.5% with SU+Metformin combination.
23.2%
22.2%
33.3%
22.3%
Renal threshold increased to --- of glucose in T2DM patient
140 mg/dl
280 mg/dl
180 mg/dl
240 mg/dl
Total pts in Dapa CKD trial were___
7404
17160
4304
4744
In Declare Timi Trial Dapagliflozin reduced HHF by ___
29%
27%
30%
33%
Meta Analysis of 17000 patients: Vildagliptin is not associated with an increased risk of ____
UTI
MACE
CKD
HF
Select Right Available Strengths of Zukanorm D
Vildagliptin 5/10 mg SR + Dapagliflozin 100mg
Vildagliptin 100mg SR + Dapagliflozin 5mg/10mg
Vildagliptin 5/10 mg SR + Dapagliflozin 100mg
Vildagliptin 10 mg SR + Dapagliflozin 10mg
Combination of Vildagliptin & Dapagliflozin complements reduction in ___. (More than 1 click possible)
Hyperglycemic parameters
GUTI
Blood Pressure
Bronchoconstriction
True or False:
SGLT2Is moderate the risk of Genitourinary tract infections when combined with DPP4Is .
True
False
True or False: The GLP-1 half-life is <2 min, whereas that of GIP is ∼5–7 min
True
False
Vildagliptin is Superior over Teneligliptin on which parameters? (More than one correct answer)
Greater Weight reduction
Greater Increase in insulin sensitivity
Greater Reduction in non-HDL-C
Greater Reduction of FBG
Patient count of VERIFY trial was ____
answer choices
1987
2001
4027
3001
Why PPG is harmful?
Hyperinsulinemia and IR: Dyslipidemia, HT, increase CAD.
Liver disease
Oxidative stress on endothelium and beta cells.
Damages endothelium: Increases CIMT (Carotid Intima Media Thickness)
Combination of Voglistar GM
Voglibose - 0.2 mg Metformin - 500 mg SR Glimepiride - 1 mg/2 mg
Voglibose - 0.2 mg Metformin - 500 mg SR Glimepiride - 2mg/4 mg
Voglibose - 0.2 mg/0.3 mg Mouth Dissolving
Voglibose - 0.2 mg/0.3 mg Metformin - 500 mg
